Global Amyotrophic Lateral Sclerosis (ALS) Market - Industry Analysis Size Share Growth Trends and Forecast 2024 - 2031

Product Description

The Amyotrophic Lateral Sclerosis (ALS) market revenue was xx Million USD in 2019, grew to xx Million USD in 2023, and will reach xx Million USD in 2031, with a CAGR of xx during 2024-2031. Considering the influence of COVID-19 on the global Amyotrophic Lateral Sclerosis (ALS) market, this report analyzed the impact from both global and regional perspectives. From production end to consumption end in regions such as North America, Europe, China, and Japan, the report put emphasis on analysis of market under COVID-19 and corresponding response policy in different regions. This report also analyzes the strategies for different companies to deal with the impact of COVID-19 in detail to seek a path to recovery. Under COVID-19 Outbreak, how the Amyotrophic Lateral Sclerosis (ALS) Industry will develop is also analyzed in detail in Chapter 1.8 of this report. Major Players in Amyotrophic Lateral Sclerosis (ALS) market are: Revalesio Corporation Gilead Sciences Biogen PTC Therapeutics/ Dainippon Sumitomo Pharma Orphazyme ABC Science Samus Therapeutics Novus Therapeutics Cytokinetics/Astellas Pharma Mitsubishi Tanabe Pharma Corporation Avanir Pharmaceuticals (a subsidiary of Otsuka America) Orion Pharma ITF Pharma (a US subsidiary Italfarmaco S.p.A.) GlaxoSmithKline Alexion Pharmaceuticals Annexon Ionis Pharmaceuticals/Biogen TikoMed AB/Neuregenix Sanofi/Covis Amylyx Pharmaceuticals Clene Nanomedicine Biohaven Pharmaceuticals Novartis Pharmaceuticals Apellis Pharmaceuticals UCB Pharma AZTherapies Brainstorm Cell Therapeutics MediciNova Aquestive Therapeutics Most important types of Amyotrophic Lateral Sclerosis (ALS) products covered in this report are: Riluzole Edaravone (Radicava) Others Most widely used downstream fields of Amyotrophic Lateral Sclerosis (ALS) market covered in this report are: Hospital Drugs Store Others Major Regions or countries covered in this report: North America Europe China Japan Middle East and Africa South America India South Korea Southeast Asia Others In Chapter 3.4, the report provides analysis of the reasons behind price fluctuations. In chapters 5, 6, and 7, the impact of COVID-19 on the different regions in both production and consumption end and SWOT analysis are pointed out. In Chapters 8, the report presents company's recent development and strategies to deal with the impact of COVID-19.